As can be seen in the following chart, Pro Medicus shares and Hansen Technologies shares have fallen 28% and 31%, respectively.
Pro Medicus is a $460 million company developing medical imaging software. Its products are used by radiologists and doctors to inspect and manipulate images in real time.
Radiology is a highly regulated field of medicine and the imagery used by doctors must be incredibly clear to meet regulatory standards. To give you a sense of just how clear it must be, consider this: When you a take photo with your new smartphone, it may produce a 5 megabyte (Mb) file size. A radiologist’s file could be 2,000 Mb (2Gb). Imagine trying to send that to a friend!
What makes Pro Medicus incredible is that it can deliver these images to a radiologist’s smartphone with regulatory-approved clarity in just seconds. The doctor can inspect and manipulate the image on the spot. 2D, 3D, or even 4D.
Hansen is a little larger than Pro Medicus, with a market capitalisation of $570 million. It develops software for customer care and billing, like the systems used by call centres and big businesses. By far, Hansen’s largest operation is in ‘billing’, creating applications for companies, such as those in pay television and telecommunications. The company’s software is ingrained with company processes, meaning a lot of its revenue is recurring.
Despite their recent performance, Hansen and Pro Medicus have performed exceptionally well over the longer-term. Therefore, the recent falls may present a compelling opportunity for savvy investors. I have both of these businesses on my watchlist in 2017.
Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading over 40% off its high, all while offering a fully franked dividend yield over 3%...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
The Motley Fool Australia owns shares of Hansen Technologies. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.